Krishnaswamy Yeleswaram

Companies

• Rapport Therapeutics, Inc.Chief Development Officer Jun 6, 2024 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• RTRapport Therapeutics, Inc. RAPP195,862 shares²$5.6M at $28.65Aug 25, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 25, 2026Sold 16,201 shares at $51.06 of Rapport Therapeutics, Inc.²
• Aug 25, 2026Sold 20,799 shares at $50.31 of Rapport Therapeutics, Inc.²
• Aug 24, 2026Sold 13,160 shares at $50.00 of Rapport Therapeutics, Inc.²
• Aug 19, 2026Sold 404 shares at $49.90 of Rapport Therapeutics, Inc.³
• Apr 17, 2026Sold 20,225 shares at $39.99 of Rapport Therapeutics, Inc.⁴
• Apr 14, 2026Sold 10,200 shares at $35.08 of Rapport Therapeutics, Inc.⁵
• Apr 13, 2026Sold 9,165 shares at $34.97 of Rapport Therapeutics, Inc.⁵
• Apr 10, 2026Sold 500 shares at $34.98 of Rapport Therapeutics, Inc.⁵
• Apr 8, 2026Sold 360 shares at $34.90 of Rapport Therapeutics, Inc.⁶
• Mar 25, 2026Sold 10,115 shares at $29.99 of Rapport Therapeutics, Inc.⁷
• Dec 31, 2025Sold 2,840 shares at $30.05 of Rapport Therapeutics, Inc.⁸
• Dec 31, 2025Granted 9,000 shares of Rapport Therapeutics, Inc.⁸